CN107858402A - A kind of murine genes type authentication method - Google Patents

A kind of murine genes type authentication method Download PDF

Info

Publication number
CN107858402A
CN107858402A CN201711177866.XA CN201711177866A CN107858402A CN 107858402 A CN107858402 A CN 107858402A CN 201711177866 A CN201711177866 A CN 201711177866A CN 107858402 A CN107858402 A CN 107858402A
Authority
CN
China
Prior art keywords
triton
authentication method
type authentication
murine genes
genes type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711177866.XA
Other languages
Chinese (zh)
Inventor
王青
陈兆煜
高筱雅
祝淑贞
韦晓波
陈志刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Third Affiliated Hospital Sun Yat Sen University
Original Assignee
Third Affiliated Hospital Sun Yat Sen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Affiliated Hospital Sun Yat Sen University filed Critical Third Affiliated Hospital Sun Yat Sen University
Priority to CN201711177866.XA priority Critical patent/CN107858402A/en
Publication of CN107858402A publication Critical patent/CN107858402A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Include handling karyocyte using 0.2%~0.4% phosphate solutions of Triton X 100 the invention provides a kind of murine genes type authentication method so that the process that intracellular nucleic acid discharges.The present invention is it has been investigated that 0.2%~0.4% phosphate solutions of Triton X 100 handle karyocyte, intracellular nucleic acid can be made to be discharged into the aqueous solution, it is further purified without using isopropanol or ethanol, pyrolysis product directly can be used for PCR amplifications, greatly reduces the step of extracting DNA, shortens the time for obtaining DNA, the efficiency for improving experiment.

Description

A kind of murine genes type authentication method
Technical field
The present invention relates to the technical field of genetic engineering, in particular to a kind of murine genes type authentication method.
Background technology
The mouse (also known as transgenic mice) of foreign gene-carrying is the important tool of human diseases research, in medical science and life The application for ordering field of scientific study is more and more extensive.Before application transgenic mice carries out scientific research, it usually needs to mouse Genotype identified, distinguish transgenic mice and wild-type mice.Murine genes identify, be related to mouse DNA acquisition, Target DNA fragments amplification, DNA electrophoresis.
DNA extraction method traditional at present includes phenol/chloroform extraction and high salt extraction method.Although these methods can obtain Higher degree and the tissue DNA compared with high yield pulp1 are taken, but has some shortcomings part:First, operating procedure is comparatively laborious, for example, it is more It is secondary to be related to centrifugation;Second, being related to excessive reagent, such as employ the reagents such as chloroform, ethanol, Proteinase K;Third, the time is inclined Long, part Experiment step includes flow overnight.Method disclosed in pertinent literature even in recent years and available reagent box (such as Vazyme, Promega and Takala company kit etc.) provide method, its DNA extraction part takes time also in 30min To between a few hours, and contain consumptive material (such as collection post) and plurality of reagents (such as lysate, neutralizer, Proteinase K). Above mentioned problem all adds experimental cost (including reagent cost, consumables cost and human cost) to a certain extent, so as to make The about operating efficiency of transgenic mice Genotyping.
The content of the invention
In view of this, a kind of the defects of the technical problem to be solved in the present invention is to overcome prior art, there is provided mouse Genotype identification method, including karyocyte is handled using 0.2%~0.4% Triton X-100 phosphate solutions so that The process that intracellular nucleic acid discharges.
In some embodiments, the karyocyte picks up from mouse tail vein blood.
In some embodiments, the collocation method of described 0.2%~0.4%% Triton X-100 phosphate solutions Including:
0.2~0.4mL Triton X-100 are dissolved in 100mL phosphate buffers, are made into 0.2%~0.4% Triton X-100 phosphate solutions.
In some embodiments, it is further comprising the steps of:
S1:Take mouse tail vein blood;
S2:Erythrocyte cracked liquid is added into tail vein, treats erythroclasis, centrifugation removes red blood cell, obtains white thin Born of the same parents are precipitated;
S3:Wash leukocyte cell pellet;
S4:The Triton X-100 phosphate solutions that content is 0.2%~0.4%, which are added in leukocyte cell pellet to handle, to be had Nucleus so that intracellular nucleic acid discharges;
S5:PCR reacts;
S6:Aobvious band is observed in gel imager.
In some embodiments, the S1 is further comprising the steps of:
S11:Fixed mouse, mousetail is wiped with cotton ball soaked in alcohol, expands caudal vein;
S12:The tail vein of rat-tail distal dilation is poked with syringe needle, 5~10ul venous blood is drawn with siphon tubule;
S13:The venous blood of acquisition is moved in the sterile EP pipes of 1.5mL of the solution of ETDA containing 10uL, then with sterile dry cotton ball By pressing mouth.
In some embodiments, the S2 is further comprising the steps of:
S21:The erythrocyte cracked liquid of 0.5mL precoolings is added into EP pipes, is mixed static 4~5 minutes on ice, is treated red thin Born of the same parents are broken complete;
S22:1000r/min is centrifuged 5 minutes, is abandoned supernatant and is removed red blood cell, obtains leukocyte cell pellet.
In some embodiments, the S3 is further comprising the steps of:
S31:Washed 2 times with PBS;
S32:1000r/min is centrifuged 2 minutes, abandons supernatant.
In some embodiments, the S4 is further comprising the steps of:
S41:Configure 0.2%~0.4% phosphate solutions of X-100 containing Triton;
S42:0.2%~0.4%Triton X-100 phosphate solutions the 0.2mL configured is added to EP pipes to be mixed Compound, concussion are resuspended, are stored at room temperature 10 minutes;
S43:Mixture after will be static centrifuges 5 minutes in 1000r/min, and supernatant is moved into new sterile EP manages, in- 80 degrees Celsius of preservations, or place on ice, operated in next step with preparing row.
In some embodiments, PCR reaction solutions composition is in the S5:
In some embodiments, PCR reaction conditions are in the S5:
Step1:Pre-degeneration:94℃、5min、1cycle;
Step2:PCR reacts:94 DEG C, 30s, 58 DEG C, 30s, 72 DEG C, 30s, 35cycle;
Step3:Thoroughly extension:72℃、7min.
In terms of existing technologies, beneficial effect is a kind of murine genes type authentication method provided by the invention:
Murine genes type authentication method provided by the invention, including use 0.2%~0.4% Triton X-100 phosphoric acid Salting liquid handles karyocyte so that the process that intracellular nucleic acid discharges.
It is understood that the method currently used for whole blood DNA extraction, special agent used is more, during whole operation Between it is longer.The present invention except with use erythrocyte cracked liquid splitting erythrocyte as other schemes in addition to, to the karyocyte of acquisition, Use the auxiliary reagent Triton X-100 (Triton X-100) in laboratory.
Triton X-100 typical concentrations are 0.025%-0.1% in immunocytochemistry, for rinsing tissue specimen, Slice surface tension force is reduced, makes reaction solution be easy to cover sample surface.Also have and think 0.025%-0.1%Triton X-100 Phosphate solution can dissolve the Fc acceptors of cell membrane surface and reduce nonspecific combination, increase the penetrating of cell membrane Property.
It is to be appreciated that the present invention is it has been investigated that 0.2%~0.4% Triton X-100 phosphate solutions are handled Karyocyte, intracellular nucleic acid can be made to be discharged into the aqueous solution, be further purified without using isopropanol or ethanol, split Solution product directly can be used for PCR amplifications, greatly reduces the step of extracting DNA, shortens acquisition DNA time, improves The efficiency of experiment.
Being studied by many experiments confirms, nonionic surface active agent Triton X-100 have under specific concentration Above-mentioned special effect.Especially, 0.2%~0.4% Triton X-100 phosphate solutions.
Further, the karyocyte picks up from mouse tail vein blood.
It is understood that the mode majority currently for the kit extraction mouse DNA of transgenic mice identification is logical Clip rat-tail, mouse ear or mouse toe is crossed to realize.
Using the One step Mouse Genotyping Kit products of Vazyme companies as representative, there is provided a whole set of DNA is thick Extraction and PCR amplification system, by adding Tissue lysates and Proteinase K, (the 55 C water bath 2- by way of water-bath 4 hours or water-bath are stayed overnight, 95 degrees Celsius of fire extinguishing Proteinase Ks), mouse tissue is discharged DNA, then directly draw cracking Liquid carries out follow-up target DNA fragments amplification and DNA electrophoretic procedures as DNA profiling.
The DNAiso Reagent that Takala companies provide also can extract DNA (traditional windings in animal tissue source Method), sample can be fully cleaved in DNAiso Reagent, after ethanol is added, it may appear that the genome of white flock DNA precipitate, collect and wash precipitation can obtain genomic DNA, operation can be completed in 30 minutes.
It is also useful on the market although rarely having the report that murine genes type is identified in a manner of whole blood extracts DNA on document In the examination kit from whole blood extraction DNA.Using the Blood Genome DNA Extraction Kit of Takala companies as generation Table, kit contain tri- kinds of GenTLE Solution I, II, III solution.Wherein GenTLE Solution I effect be It is globulicidal simultaneously, with nucleic acid formed electroneutral complex.The complex is collected by centrifugation and uses GenTLE After Solution II cleanings, GenTLE Solution III are added in precipitation, DNA is separated, then added different DNA is precipitated and reclaimed by propyl alcohol, and whole operation needs 40 minutes or so.
The TaKaRa MiniBEST Whole Blood Genomic DNA Extraction Kit of Takala companies are adopted Use column method.The kit, which is used to add in erythroplastid (such as mammal) whole blood of various anti-coagulants from 1uL~1mL, to be carried Genomic DNA is taken, a large amount of erythroplastids in whole blood are cracked using special erythrocyte splitting method, then by cell pyrolysis liquid Cracking leucocyte simultaneously discharges genomic DNA, and membrane technology purified genomic dna is prepared in conjunction with DNA.
It follows that currently for transgenic mice identification it is tissue-derived be typically the rat-tail of clip, mouse ear or Mouse toe, larger wound is caused to experiment mice, and causes larger stress reaction, and be not easy after clip tissue hemostasis or Bleeding stopping period is longer.The present invention from mouse rat-tail by gathering venous blood, it is only necessary to gathers 5~10 microlitres of venous blood, mitigates to small The wound and stress reaction of mouse, and convenient hemostasis.
In summary, a kind of murine genes type authentication method provided by the invention has the advantages of above-mentioned many and value, And similar method is there are no in like product and publishes or uses and really belong to innovation, generate handy and practical effect Fruit, more existing technology have the multinomial effect promoted, and so as to more be suitable to practicality, and have extensive industrial value.
Brief description of the drawings
It should be appreciated that the following drawings illustrate only certain embodiments of the present invention, therefore it is not construed as to model The restriction enclosed, for those of ordinary skill in the art, on the premise of not paying creative work, can also be according to these Accompanying drawing obtains other related accompanying drawings.
Fig. 1 is method disclosed in embodiment of the present invention to 3 alpha-synapse nucleoprotein A53T mutation transgenes mouse and 3 The wild-type mice of littermate carries out the result of identified for genes;
Fig. 2 is the One step Mouse Genotyping Kit of Vazyme companies method to 3 α-cynapse core egg The wild-type mice of white A53T mutation transgenes mouse and 3 littermates carries out the result of identified for genes.
Wherein, "+" represents transgenic mice, and "-" represents wild-type mice.Agargel electrophoresis qualification result:It is mutated bar Band is located at 500bp, and wild type occurs without band.Both sides swimming lane is DNA marker: 100bp、200bp、300bp、400bp、 500bp、700bp、1000bp。
Embodiment
Hereinafter, the present invention will be described more fully with conjunction with the embodiments.The disclosure can have various embodiments, and can Adjust and change wherein.It should be understood, however, that:It is disclosed herein specific in the absence of the various embodiments of the disclosure are limited to The intention of embodiment, but the disclosure should be interpreted as to covering the institute in the spirit and scope for the various embodiments for falling into the disclosure There are adjustment, equivalent and/or alternative.
Hereinafter, disclosed in the term " comprising " that can be used in the various embodiments of the disclosure or " may include " instruction Function, operation or the presence of element, and do not limit the increase of one or more functions, operation or element.
In the various embodiments of the disclosure, stating "or" or " at least one in A or/and B " includes what is listed file names with Any combinations of word or all combinations.For example, " A or B " or " at least one in A or/and B " may include A, Ke Bao for statement Include B or may include A and B both.
The statement (" first ", " second " etc.) used in the various embodiments of the disclosure can be modified in various implementations Various element in example, but respective sets can not be limited into element.For example, presented above be not intended to limit the suitable of the element Sequence and/or importance.The purpose presented above for being only used for differentiating an element and other elements.For example, the first user fills Put and indicate different user device with second user device, although the two is all user's set.For example, each of the disclosure is not being departed from In the case of the scope of kind embodiment, the first element is referred to alternatively as the second element, and similarly, the second element is also referred to as first Element.
It should be noted that:, can be by the first composition member if an element ' attach ' to another element by description Part is directly connected to the second element, and " connection " the 3rd can be formed between the first element and the second element Element.On the contrary, when an element " being directly connected to " is arrived into another element, it will be appreciated that be in the first element And second be not present the 3rd element between element.
The term used in the various embodiments of the disclosure is only used for describing the purpose of specific embodiment and not anticipated In the various embodiments of the limitation disclosure.As used herein, singulative is intended to also include plural form, unless context is clear Chu it is indicated otherwise.Unless otherwise defined, all terms (including the technical term and scientific terminology) tool being otherwise used herein There is the implication identical implication that the various embodiment one skilled in the art with the disclosure are generally understood that.The term (term such as limited in the dictionary typically used) is to be interpreted as having and the situational meaning in correlative technology field Identical implication and the implication with Utopian implication or overly formal will be not construed as, unless in the various of the disclosure It is clearly defined in embodiment.
In some embodiments of the invention, a kind of murine genes type authentication method, including using 0.2%~0.4% Triton X-100 phosphate solutions handle karyocyte so that the process that intracellular nucleic acid discharges.
It is above-mentioned, it is to be understood that currently used for the method for whole blood DNA extraction, special agent used is more, whole behaviour It is longer to make the time.The present invention except with as other schemes use erythrocyte cracked liquid splitting erythrocyte in addition to, have core to acquisition Cell, use the auxiliary reagent Triton X-100 (Triton X-100) in laboratory.
Triton X-100 typical concentrations are 0.025%-0.1% in immunocytochemistry, for rinsing tissue specimen, Slice surface tension force is reduced, makes reaction solution be easy to cover sample surface.Also have and think 0.025%-0.1%Triton X-100 Phosphate solution can dissolve the Fc acceptors of cell membrane surface and reduce nonspecific combination, increase the penetrating of cell membrane Property.
It is to be appreciated that the present invention is it has been investigated that 0.2%~0.4% Triton X-100 phosphate solutions are handled Karyocyte, intracellular nucleic acid can be made to be discharged into the aqueous solution, be further purified without using isopropanol or ethanol, split Solution product directly can be used for PCR amplifications, greatly reduces the step of extracting DNA, shortens acquisition DNA time, improves The efficiency of experiment.
Being studied by many experiments confirms, nonionic surface active agent Triton X-100 have under specific concentration Above-mentioned special effect.Especially, 0.2%~0.4% Triton X-100 phosphate solutions.
In some embodiments of the present invention, the karyocyte picks up from mouse tail vein blood.
In some embodiments of the present invention, the configuration of described 0.2%~0.4% Triton X-100 phosphate solutions Method includes:
0.2~0.4mL Triton X-100 are dissolved in 100mL phosphate buffers, are made into 0.2%~0.4% Triton X-100 phosphate solutions.
It is further comprising the steps of in some embodiments of the present invention:
S1:Take mouse tail vein blood;
S2:Erythrocyte cracked liquid is added into tail vein, treats erythroclasis, centrifugation removes red blood cell, obtains white thin Born of the same parents are precipitated;
S3:Wash leukocyte cell pellet;
S4:The Triton X-100 phosphate solutions that content is 0.2%~0.4%, which are added in leukocyte cell pellet to handle, to be had Nucleus so that intracellular nucleic acid discharges;
S5:PCR reacts;
S6:Aobvious band is observed in gel imager.
In some embodiments of the present invention, the S1 is further comprising the steps of:
S11:Fixed mouse, mousetail is wiped with cotton ball soaked in alcohol, expands caudal vein;
S12:The tail vein of rat-tail distal dilation is poked with syringe needle, 5~10ul venous blood is drawn with siphon tubule;
S13:The venous blood of acquisition is moved in the sterile EP pipes of 1.5mL of the solution of ETDA containing 10uL, then with sterile dry cotton ball By pressing mouth.
In some embodiments of the present invention, the S2 is further comprising the steps of:
S21:The erythrocyte cracked liquid of 0.5mL precoolings is added into EP pipes, is mixed static 4~5 minutes on ice, is treated red thin Born of the same parents are broken complete;
S22:1000r/min is centrifuged 5 minutes, is abandoned supernatant and is removed red blood cell, obtains leukocyte cell pellet.
In some embodiments of the present invention, the S3 is further comprising the steps of:
S31:Washed 2 times with PBS;
S32:1000r/min is centrifuged 2 minutes, abandons supernatant.
In some embodiments of the present invention, the S4 is further comprising the steps of:
S41:Configure 0.2%~0.4% phosphate solutions of X-100 containing Triton;
S42:0.2%~0.4%Triton X-100 phosphate solutions the 0.2mL configured is added to EP pipes to be mixed Compound, concussion are resuspended, are stored at room temperature 10 minutes;
S43:Mixture after will be static centrifuges 5 minutes in 1000r/min, and supernatant is moved into new sterile EP manages, in- 80 degrees Celsius of preservations, or place on ice, operated in next step with preparing row.
In some embodiments of the present invention, PCR reaction solutions composition is in the S5:
In some embodiments of the present invention, PCR reaction conditions are in the S5:
Step1:Pre-degeneration:94℃、5min、1cycle;
Step2:PCR reacts:94 DEG C, 30s, 58 DEG C, 30s, 72 DEG C, 30s, 35cycle;
Step3:Thoroughly extension:72℃、7min.
Following embodiment facilitates a better understanding of the present invention, but does not limit the present invention.
Embodiment 1
(1) fixed mouse, mousetail is wiped with cotton ball soaked in alcohol, expands caudal vein, it is remote to poke rat-tail with No. 4 syringe needles Hold the tail vein of expansion, 5uL venous blood drawn with siphon tubule, with i.e. by blood move to the 1.5mL of the solution of ETDA containing 10ul without Bacterium EP is managed, and pressing mouth is pressed with sterile dry cotton ball;
(2) toward the erythrocyte cracked liquid of addition 0.5mL precoolings in EP pipes, mix static 4 minutes on ice, treat that red blood cell is complete Broken, 1000r/min is centrifuged 5 minutes, is abandoned supernatant, is obtained leukocyte cell pellet, is washed 2 times with PBS, and 1000r/min centrifuges 2 points Clock, abandon supernatant.
(3) 0.2% phosphate solutions of X-100 containing Triton are configured, add 0.2mL toward EP pipes, concussion is resuspended, and room temperature is quiet Put 10 minutes, 1000r/min is centrifuged 5 minutes, and supernatant is moved into new sterile EP manages, in -80 degrees Celsius of preservations, or on ice Place, operated in next step with preparing row.
(4) DNA profiling of extraction is used for condition when PCR reacts
1) PCR reaction solutions form
2) PCR reaction conditions
Step1:Pre-degeneration:94℃、5min、1cycle;
Step2:PCR reacts:94 DEG C, 30s, 58 DEG C, 30s, 72 DEG C, 30s, 35cycle;
Step3:Thoroughly extension:72℃、7min
(5) agargel electrophoresis, 150V, 25min, observed in gel imager.
Embodiment 2
(1) fixed mouse, mousetail is wiped with cotton ball soaked in alcohol, expands caudal vein, it is remote to poke rat-tail with No. 3 syringe needles The tail vein of expansion is held, 10uL venous blood is drawn with siphon tubule, with the 1.5mL that blood is moved to the solution of ETDA containing 10uL Sterile EP pipes, pressing mouth is pressed with sterile dry cotton ball.
(2) toward the erythrocyte cracked liquid of addition 0.5mL precoolings in EP pipes, mix static 5 minutes on ice, treat that red blood cell is complete Broken, 1000r/min is centrifuged 5 minutes, is abandoned supernatant, is obtained leukocyte cell pellet, is washed 2 times with PBS, and 1000r/min centrifuges 2 points Clock, abandon supernatant.
(3) 0.4% phosphate solutions of X-100 containing Triton are configured, add 0.2mL toward EP pipes, concussion is resuspended, and room temperature is quiet Put 10 minutes, 1000r/min is centrifuged 5 minutes, and supernatant is moved into new sterile EP manages, in -80 degrees Celsius of preservations, or on ice Place, operated in next step with preparing row.
(4) DNA profiling of extraction is used for condition when PCR reacts
1) PCR reaction solutions form
2) PCR reaction conditions
Step1:Pre-degeneration:94℃、5min、1cycle;
Step2:PCR reacts:94 DEG C, 30s, 58 DEG C, 30s, 72 DEG C, 30s, 35cycle;
Step3:Thoroughly extension:72℃、7min
(5) agargel electrophoresis, 150V, 25min, observed in gel imager.
It should be appreciated that although the present specification is described in terms of embodiments, not each embodiment only includes one Individual independent technical scheme, this narrating mode of specification is only that those skilled in the art will should say for clarity For bright book as an entirety, the technical scheme in each embodiment may also be suitably combined to form those skilled in the art can With the other embodiment of understanding.
Inventor states that the present invention can only for of the invention by a series of describe in detail of those listed above Row embodiment illustrates, but the invention is not limited in above-mentioned detailed process equipment and technological process.And i.e. not Mean that the present invention should rely on above-mentioned detailed process equipment and technological process and could implement.Person of ordinary skill in the field should This is clear, any improvement in the present invention, and the equivalence replacement and auxiliary element to each raw material of product of the present invention are added, are specific square Selection of formula etc., within the scope of all falling within protection scope of the present invention and disclosing.

Claims (10)

  1. A kind of 1. murine genes type authentication method, it is characterised in that:Including the Triton X-100 phosphorus using 0.2%~0.4% Acid salt solution handles karyocyte so that the process that intracellular nucleic acid discharges.
  2. A kind of 2. murine genes type authentication method as claimed in claim 1, it is characterised in that:The karyocyte picks up from mouse Tail vein.
  3. A kind of 3. murine genes type authentication method as claimed in claim 2, it is characterised in that:Described 0.2%~0.4% The collocation method of Triton X-100 phosphate solutions includes:
    0.2~0.4mL Triton X-100 are dissolved in 100mL phosphate buffers, are made into 0.2%~0.4% Triton X-100 phosphate solutions.
  4. A kind of 4. murine genes type authentication method as claimed in claim 1, it is characterised in that:It is further comprising the steps of:
    S1:Take mouse tail vein blood;
    S2:Erythrocyte cracked liquid is added into tail vein, treats erythroclasis, centrifugation removes red blood cell, obtains leucocyte and sink Form sediment;
    S3:Wash leukocyte cell pellet;
    S4:The Triton X-100 phosphate solutions that content is 0.2%~0.4% are added into processing in leukocyte cell pellet has core thin Born of the same parents so that intracellular nucleic acid discharges;
    S5:PCR reacts;
    S6:Aobvious band is observed in gel imager.
  5. A kind of 5. murine genes type authentication method as claimed in claim 4, it is characterised in that:The S1 also includes following step Suddenly:
    S11:Fixed mouse, mousetail is wiped with cotton ball soaked in alcohol, expands caudal vein;
    S12:The tail vein of rat-tail distal dilation is poked with syringe needle, 5~10ul venous blood is drawn with siphon tubule;
    S13:The venous blood of acquisition is moved in the sterile EP pipes of 1.5mL of the solution of ETDA containing 10uL, then pressed with sterile dry cotton ball Pin mouth.
  6. A kind of 6. murine genes type authentication method as claimed in claim 4, it is characterised in that:The S2 also includes following step Suddenly:
    S21:The erythrocyte cracked liquid of 0.5mL precoolings is added into EP pipes, mixes static 4~5 minutes on ice, treats erythroclasis Completely;
    S22:1000r/min is centrifuged 5 minutes, is abandoned supernatant and is removed red blood cell, obtains leukocyte cell pellet.
  7. A kind of 7. murine genes type authentication method as claimed in claim 4, it is characterised in that:The S3 also includes following step Suddenly:
    S31:Washed 2 times with PBS;
    S32:1000r/min is centrifuged 2 minutes, abandons supernatant.
  8. A kind of 8. murine genes type authentication method as claimed in claim 4, it is characterised in that:The S4 also includes following step Suddenly:
    S41:Configure 0.2%~0.4% phosphate solutions of X-100 containing Triton;
    S42:0.2%~0.4%Triton X-100 phosphate solutions the 0.2mL configured is added to EP pipes and obtains mixture, Concussion is resuspended, and is stored at room temperature 10 minutes;
    S43:Mixture after will be static centrifuges 5 minutes in 1000r/min, and supernatant is moved into new sterile EP manages, and is taken the photograph in -80 Family name's degree preserves, or places on ice, is operated in next step with preparing row.
  9. A kind of 9. murine genes type authentication method as claimed in claim 4, it is characterised in that:PCR reaction solutions group in the S5 Turn into:
  10. A kind of 10. murine genes type authentication method as claimed in claim 4, it is characterised in that:PCR reaction conditions in the S5 For:
    Step1:Pre-degeneration:94℃、5min、1cycle;
    Step2:PCR reacts:94 DEG C, 30s, 58 DEG C, 30s, 72 DEG C, 30s, 35cycle;
    Step3:Thoroughly extension:72℃、7min.
CN201711177866.XA 2017-11-21 2017-11-21 A kind of murine genes type authentication method Pending CN107858402A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711177866.XA CN107858402A (en) 2017-11-21 2017-11-21 A kind of murine genes type authentication method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711177866.XA CN107858402A (en) 2017-11-21 2017-11-21 A kind of murine genes type authentication method

Publications (1)

Publication Number Publication Date
CN107858402A true CN107858402A (en) 2018-03-30

Family

ID=61702351

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711177866.XA Pending CN107858402A (en) 2017-11-21 2017-11-21 A kind of murine genes type authentication method

Country Status (1)

Country Link
CN (1) CN107858402A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110904241A (en) * 2018-09-14 2020-03-24 广州铂晋生物科技有限公司 Rapid identification method for transgenic mouse genotype

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060240449A1 (en) * 2005-01-19 2006-10-26 Mcglennen Ronald C Methods and compositions for preparation of biological samples
CN101122601A (en) * 2007-09-24 2008-02-13 孙艳萍 Method for separating and authenticating erythroblast of blood
CN102914657A (en) * 2012-10-10 2013-02-06 中国人民解放军军事医学科学院放射与辐射医学研究所 Method for detecting protein in peripheral blood karyocyte cells
CN105734051A (en) * 2016-03-18 2016-07-06 中国人民解放军第三军医大学第三附属医院 Genotyping-based kit and method for extracting DNA of transgenic mice

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060240449A1 (en) * 2005-01-19 2006-10-26 Mcglennen Ronald C Methods and compositions for preparation of biological samples
CN101122601A (en) * 2007-09-24 2008-02-13 孙艳萍 Method for separating and authenticating erythroblast of blood
CN102914657A (en) * 2012-10-10 2013-02-06 中国人民解放军军事医学科学院放射与辐射医学研究所 Method for detecting protein in peripheral blood karyocyte cells
CN105734051A (en) * 2016-03-18 2016-07-06 中国人民解放军第三军医大学第三附属医院 Genotyping-based kit and method for extracting DNA of transgenic mice

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110904241A (en) * 2018-09-14 2020-03-24 广州铂晋生物科技有限公司 Rapid identification method for transgenic mouse genotype

Similar Documents

Publication Publication Date Title
TWI378103B (en) Corn event tc1507 and methods for detection thereof
Black Disaster anthropology: the 2004 Asian tsunami
Inoue et al. Japanese macaque microsatellite PCR primers for paternity testing
Ravelonandro et al. The efficiency of RNA interference for conferring stable resistance to Plum pox virus
JP2006506057A (en) DNA extraction from biological samples
CN101368179B (en) Reagent kit for extracting DNA in Chinese alligator chorion film and use method thereof
CN107858402A (en) A kind of murine genes type authentication method
CN107058297B (en) A kind of chaotropic agent and the method using chaotropic agent extraction genomic DNA
Lucas et al. Genetic analysis of powdery mildew disease in Turkish hazelnut
CN103088136A (en) Primer and identifying method for identifying different genetic collateral series of aphelinid
CN107475398A (en) Detect the primer and method of IKZF1 gene mutation typings
JP2016140289A (en) Identification assisting method of species of eel
Vea et al. The B chromosome of Pseudococcus viburni: a selfish chromosome that exploits whole-genome meiotic drive
CN107354233B (en) Microsatellite primer for identifying sex of bee eggs of fly pupae trichogramma, application and method for identifying sex of bee eggs of fly pupae trichogramma
CN109880822A (en) A kind of idesia high quality DNA extracting method
Yang et al. A simple and rapid gene amplification from Arabidopsis leaves using AnyDirect system
CN107699561A (en) A kind of modified CTAB method extracts cotton genomic dna
Peterson et al. Sequencing plant genomes
WO2016090965A1 (en) Hmg1 gene and uses thereof in microsporidium molecular detection
CN109609681B (en) Identification method of loblolly pine individual based on chloroplast genome sequence
Di Bernardo et al. Ancient DNA and family relationships in a Pompeian house
CN106591426A (en) COI gene standard complete sequence and molecular identification method of hoolock leuconedys
de Lourdes Muñoz et al. Extraction and electrophoresis of DNA from the remains of Mexican ancient populations
CN109913476A (en) Bat source adeno-associated virus genome, amplimer and its application, amplification method
Ramadass Cloning

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180330

RJ01 Rejection of invention patent application after publication